Participation of p53 protein in the cellular response to DNA damage.
暂无分享,去创建一个
[1] L. R. Gurley,et al. Effects of caffeine on radiation-induced phenomena associated with cell-cycle traverse of mammalian cells. , 1974, Biophysical journal.
[2] N. Cozzarelli,et al. Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine , 1976, Nature.
[3] R. W. Jones,et al. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. , 1977, Radiation research.
[4] M. Kastan,et al. Distribution of repair-incorporated nucleotides and nucleosome rearrangement in the chromatin of normal and xeroderma pigmentosum human fibroblasts. , 1979, Biochemistry.
[5] D. Lane,et al. T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.
[6] R. Painter,et al. Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Doll,et al. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.
[8] A. Levine,et al. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells , 1981, Molecular and cellular biology.
[9] J. Fraumeni,et al. Prospective study of a family cancer syndrome. , 1982, JAMA.
[10] A. Pardee,et al. Mechanism by which caffeine potentiates lethality of nitrogen mustard. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[12] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[13] A. Levine,et al. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.
[14] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[15] R. Craig,et al. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. , 1984, Cancer research.
[16] J. Jenkins,et al. Precise epitope mapping of the murine transformation‐associated protein, p53. , 1985, The EMBO journal.
[17] M. Oren,et al. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors , 1985, Molecular and cellular biology.
[18] J. Yunis. Genes and chromosomes in human cancer. , 1985, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.
[19] V. Rotter,et al. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. E. Sippel,et al. Subnuclear localization of proteins encoded by the oncogene v-myb and its cellular homolog c-myb , 1986, Molecular and cellular biology.
[21] J. Denekamp,et al. Cell kinetics and radiation biology. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[22] M. Oren,et al. Oligomerization of oncoprotein p53 , 1988, Journal of virology.
[23] L. Hartwell,et al. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.
[24] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[25] M. Muller,et al. Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Schimke,et al. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram. , 1989, Cytometry.
[27] J. Chirgwin,et al. Isolation of RNA. , 1989, Methods in enzymology.
[28] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[29] M. Kastan,et al. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. , 1989, Blood.
[30] M. Oren,et al. Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Slamon,et al. Expression of protooncogene c-myb in normal human hematopoietic cells. , 1989, Blood.
[32] W. Blattner,et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.
[33] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[34] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[35] E. Appella,et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Vogelstein. A deadly inheritance , 1990, Nature.
[37] L. Strong,et al. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. , 1990, Cancer research.
[38] J. Milner,et al. p53 is associated with p34cdc2 in transformed cells. , 1990, The EMBO journal.
[39] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[40] A. Balmain,et al. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.
[41] P. Friedman,et al. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Lock,et al. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. , 1990, Cancer research.
[43] B. Vogelstein,et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.
[44] K. Kohn,et al. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II. , 1990, Molecular pharmacology.
[45] L. Hartwell,et al. Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage , 1990, Molecular and cellular biology.
[46] L. Ellwein,et al. Cell proliferation in carcinogenesis. , 1990, Science.
[47] B. Vogelstein,et al. p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.
[48] A. Levine,et al. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. , 1991, Genes & development.
[49] C. Marshall. Tumor suppressor genes , 1991, Cell.
[50] C. Wolkow,et al. Levels of p53 protein increase with maturation in human hematopoietic cells. , 1991, Cancer research.
[51] P. Green,et al. Identification of p53 gene mutations in bladder cancers and urine samples. , 1991, Science.
[52] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.